Navigation
banner
Together we Drive the Future

Stem Cell Summit 2017

2017-04-272017-03-092017-02-13
Register 3 for the price of 2 with the coupon code rcdvb!


registration button

Stem Cell Summit 2017


Stem Cell Research & Regenerative Medicine 2017

Stem Cell Product Development & Commercialization 2017
 
 

Subscribe for updates



Dear Colleague,

GTCbio is proud to present the Stem Cell Summit 2017, to be held on April 5-7, 2017 in Boston, MA. The Stem Cell Summit provides information on cutting-edge developments in all areas of stem cell research from bench to bedside, including the biology, medicine, applications, regulations, product development, and the commercialization of stem cells. This summit comprises of presentations, panels and round-table discussions to highlight pre-clinical and clinical studies in regenerative medicine, immunotherapy, stem cell reprogramming, cell therapy in diabetes, regulatory policies regarding stem cell research, manufacturing and other relevant topics.

 
Stem Cell Summit 2017
 includes two back-to-back conferences including joint plenary session:

 
Conference 1: 14th Stem Cell Research & Regenerative Medicine

  1. Advances in Adult & Pluripotent Stem Cell Research
  2. Revolution in Immunotherapy
  3. What’s in the Pipeline: Pre-clinical & Clinical Strategies

Joint: Plenary Session

  1. Where do We Stand with Cell Therapy in Diabetes?

Conference 2: 6th Stem Cell Product Development & Commercialization

  1. Regulatory Challenges in Cell Therapy
  2. Funding and Partnering
  3. Stem Cells for Drug Discovery & Disease Modeling
  4. Manufacturing and Scalable Processes
  5. Biotech Showcase: Emerging Pipelines
  6. Commercialization: Creating Sustainable Business Models

 

Best regards,

The 2017 Advisory Committee

2017 Advisory Board Members
Stephen Chang, The New York Stem Cell Foundation
Douglas Losordo, Caladrius Biosciences
Robert Deans, BlueRock Therapeutics
Alain Vertes, NxR Biotechnologies GmbH
Daniel Anderson, Massachusetts Institute of Technology
Edward Lanphier, Sangamo Biosciences
Khalid Shah, Harvard Medical School; Massachusetts General Hospital
Yang (Ted) Teng, Harvard University and Spaulding Rehabilitation Hospital
James Ankrum, University of Iowa
Hardy T S Kagimoto, Healios K.K (RIKEN Venture)
Anthony Ting, Athersys
Robert Halliwell, University of the Pacific
Devyn Smith, Pfizer
Jiwen Zhang, GE Healthcare
Julie G. Allickson, Wake Forest Institute for Regenerative Medicine
Tiina Palomaki, Finnish Medicines Agency
Satish Medicetty, GTCbio